The Department of Pharmaceuticals (DoP) on March 10, 2026, issued the Bio Pharma SHAKTI scheme.
The following has been stated:
• The Government has announced the Biopharma SHAKTI scheme with an outlay of ₹10,000 crore over five years to strengthen the domestic biopharmaceutical sector and make India a global hub for biologics and biosimilars manufacturing and innovation.
• The initiative aims to support development and manufacturing of high-value biopharma products, reduce import dependence, and improve India’s position in the global biologics supply chain.
• The scheme also proposes expansion of the biopharma ecosystem by establishing three new National Institute of Pharmaceutical Education and Research (NIPERs) and upgrading seven existing ones, building a large-scale clinical research ecosystem, strengthening the regulatory framework through the Central Drugs Standard Control Organisation, and providing early-stage funding and equity support for startups and industry innovation.
[Press release id - 2237416]
